Member Info for Magsy18

It’s not just me though. The market has disagreed with you for weeks.

These discrepancies in market cap are not new and so throwing out a bunch of market caps to compare, with zero context, doesn’t really progress things.

There is far more repetitive nonsense on these boards from people spouting ridiculous share price ramps. Why aren’t you calling out these people?

Only one of us resorts to insults, they don’t strengthen your points.

NCYT should look at getting some partnerships together then to help them compare to us. Wonder if GSK or AZ are interested. Obviously they aren’t as big as Cytiva but it would help them out.

I think you’ll find that the most amusing thing is that you saw that as a serious statement.

You’re a clever boy.

We are genuinely lucky to have such an experienced trader on board like yourself Nickel. Gives me confidence that we will hit your £2 by close.

Rolling, hope you feel better about yourself after feeling the need to throw out the insults.

Can you go into a bit more detail on the NCYT comparison please to help the board.

Can you show us why higher margins on £0 of sales means that we should compare directly with NCYT with £90m of sales. Please show some basic rough calculations to support the comparison.

Will be really useful info for the board so thanks in advance.

Rolling thanks for clearing up that market caps are valuations and not just numbers. I have learnt much from you in such a short amount of time.

And also why is it always that market caps higher than GDR are all classed as being valued fairly? Maybe they are overvalued and GDR is the one being fairly valued?

Yeah market caps are just numbers which have nothing to back them up. It doesn’t matter that we have no sales and NCYT have £90m.

Andy, predictions have now become fact? Ok, let’s see if this tests 270-300p today.

Why do you have to spoil it Silverbackboy? Plenty of genuine excitement building about heading towards 200p and then you couldn’t help make some ridiculous ramp about 270-300p.

Yeah I agree. 20% rise due to speculation on an interview that might not even happen? Come on guys, be serious.

NCYT has £90m in sales so based on that you would expect them to be higher.
Do you think AVCT and ODX are fairly valued or do you think they are overvalued?

No way this will hit 200p today unless there is some sales news and it’s too early for that.

Yeah, looks like things are starting to gain some momentum.

Good work chaps on the media contacting!

Your investment will have no impact on anyone but yourself. It really only takes an hour or so to read through the most recent RNS’s with the 5th May one being a great start.

Why should anyone do your job for you? GDR doesn’t need your investment.

It’s a fair point Jack and I freely admit that I focus more on questioning positives than negatives.

I am invested in this share and realistically there are scenarios where this could legitimately 3 or 4 bag but dwelling on that just isn’t healthy and so it’s important to keep those expectations in check. It’s easy to come on a forum like this and have all your expectations confirmed and then some but questioning them openly, I find a really good way of managing my own expectations.

So, I am more positive about this share than it might seem.

Does the above resonate with anyone else? I can’t be alone in this way of thinking?

I admire the consistency.

HSBC buys. This is good news, great to get a name like HSBC involved.
HSBC sells. This is good news, great to get the big sellers out the way.

Why is there always some comment wondering why II’s offload?

Newsflash, II’s behave differently to PI’s.

These companies have policies in place to manage risk and exposure to the market. It could well be that internal policy forces them to sell these shares. They don’t get emotionally attached to shares like the amateurs here.